Alitretinoin in the treatment of cutaneous T‐cell lymphoma

Alitretinoin in the treatment of cutaneous T‐cell lymphoma

Abstract Introduction In this survey, we analyzed data from patients suffering from the most common cutaneous T‐cell lymphomas (CTCLs) subtypes mycosis fungoides (MF) and Sézary syndrome (SS), treated with the retinoid alitretinoin during a 7‐year period at our outpatient department between 2015 and...

Full description

Bibliographic Details
Main Authors: Till Kaemmerer, Pia‐Charlotte Stadler, Leonie Helene Frommherz, Anne Guertler, Lars Einar French, Markus Reinholz
Format: Article
Language:English
Published: Wiley 2021-10-01
Series:Cancer Medicine
Subjects:
cancer management
drug discovery and delivery
non‐Hodgkin's lymphoma
survival
Online Access:https://doi.org/10.1002/cam4.4237

Internet

https://doi.org/10.1002/cam4.4237

Similar Items